Q2
LONG ANSWER
10M
★ High-yield
Classify the renal function tests. Describe the assessment of glomerular filtration rate and the tests of tubular function.
Functions of the Kidney
- Excretory — urea, creatinine, uric acid, drugs
- Regulatory — water, electrolytes, acid–base balance
- Endocrine — erythropoietin, renin, 1α-hydroxylase (calcitriol)
- Metabolic — gluconeogenesis, ammoniagenesis, peptide degradation
Classification of Tests
| Group | Tests |
|---|---|
| Glomerular function | Blood urea, serum creatinine, creatinine clearance, eGFR, cystatin C, inulin clearance |
| Tubular function | Urine concentration and dilution, urine specific gravity and osmolality, urinary acidification, PAH clearance |
| Glomerular integrity | Proteinuria, microalbuminuria, urine microscopy for casts |
| Others | Electrolytes, acid–base, calcium and phosphate |
Glomerular Filtration Rate
GFR = the volume of plasma filtered by the glomeruli per minute. Normal 120–130 mL/min/1.73 m2.
| Marker | Merit | Limitation |
|---|---|---|
| Inulin clearance | Gold standard — freely filtered, neither secreted nor reabsorbed | Needs infusion; impractical |
| Creatinine clearance | Endogenous; no infusion needed | Overestimates GFR by 10–20% because some is secreted; needs a complete 24-hour collection |
| Serum creatinine | Simple, cheap, universal | Insensitive — stays normal until GFR has fallen by about 50%; varies with muscle mass |
| EGFR (CKD-EPI, MDRD) | Corrects for age, sex and race; no collection needed | Unreliable at extremes of muscle mass, in pregnancy and in acute illness |
| Cystatin C | Independent of muscle mass; detects early loss | Costlier; affected by steroids and thyroid disease |
Creatinine clearance = (U × V) ÷ PU = urine creatinine, V = urine flow (mL/min), P = plasma creatinine
CLINICAL PEARL
The "creatinine blind range" matters clinically. Serum creatinine can remain within the reference interval while half the renal function has already been lost, because of the reciprocal relationship between creatinine and GFR. A rise from 0.8 to 1.6 mg/dL — both "normal-looking" — represents a halving of GFR.
Blood Urea and Creatinine
| Feature | Blood urea | Serum creatinine |
|---|---|---|
| Normal | 20–40 mg/dL | 0.6–1.2 mg/dL |
| Source | Protein catabolism, urea cycle | Creatine phosphate, non-enzymatically |
| Affected by diet | Yes — high protein raises it | Little |
| Reabsorbed | 40–50% | Negligible |
| Better index of GFR | No | Yes |
| Raised in GI bleed | Yes | No |
- Urea : creatinine ratio above 20:1 suggests a prerenal cause — dehydration, shock, gastrointestinal bleeding, or a high protein load
- Blood urea is low in liver failure, pregnancy and a low-protein diet
Tubular Function Tests
- Urine concentration test — after overnight fluid deprivation, specific gravity should exceed 1.022 and osmolality 800 mOsm/kg. Loss of concentrating ability is the earliest sign of tubular damage
- Urine dilution test — specific gravity should fall below 1.003 after a water load
- Urinary acidification (ammonium chloride loading) — urine pH should fall below 5.3; failure indicates renal tubular acidosis
- PAH clearance measures effective renal plasma flow (about 600 mL/min), since PAH is completely cleared in one pass
- Fractional excretion of sodium — below 1% in prerenal failure, above 2% in acute tubular necrosis
Proteinuria and Albuminuria
| Category | Albumin excretion | Significance |
|---|---|---|
| Normal | < 30 mg/day | — |
| Microalbuminuria | 30–300 mg/day | Earliest sign of diabetic nephropathy — and reversible |
| Overt proteinuria | > 300 mg/day | Established nephropathy |
| Nephrotic range | > 3.5 g/day | With hypoalbuminaemia, oedema and hyperlipidaemia |
- Ordinary dipsticks detect albumin but miss Bence Jones protein — a critical limitation in suspected myeloma
- Albumin : creatinine ratio on a spot sample has largely replaced timed collections
Biochemical Findings in Renal Failure
| Parameter | Change | Reason |
|---|---|---|
| Urea and creatinine | ↑↑ | Failure of excretion |
| Potassium | ↑ | Failure of excretion; acidosis shifts it out of cells |
| Bicarbonate, pH | ↓ | Failure of acid excretion and bicarbonate regeneration |
| Calcium | ↓ | Failed 1α-hydroxylation of vitamin D |
| Phosphate | ↑ | Failure of excretion |
| PTH | ↑↑ | Secondary hyperparathyroidism → renal osteodystrophy |
| Haemoglobin | ↓ | Erythropoietin deficiency |
Applied Aspects
- Annual microalbuminuria screening in diabetes is worthwhile precisely because that stage is reversible with ACE inhibitors and good glycaemic control
- Serum creatinine must be interpreted against muscle mass — a frail elderly woman may have marked impairment with a "normal" value, which is why eGFR is reported
- Drug dosing must be adjusted to eGFR for renally excreted drugs; metformin, digoxin and aminoglycosides are common pitfalls
- Cooked meat transiently raises creatinine, so a fasting sample is preferred
- Uraemia is a clinical syndrome, not a number — nausea, pruritus, pericarditis, encephalopathy and bleeding from platelet dysfunction
All questions in Clinical & Applied Biochemistry
- Q1Classify the liver function tests. Describe the biochemical findings in the three types of jaundice. ★
- Q2Classify the renal function tests. Describe the assessment of glomerular filtration rate and the tests of tubular function. ★
- Q3Describe the biosynthesis of haem and its regulation. Classify the porphyrias and add a note on lead poisoning. ★
- Q4Classify the acid–base disorders. Describe their causes, compensation and the use of the anion gap. ★
- Q5Describe the formation, transport, conjugation and excretion of bilirubin. Classify jaundice and add a note on neonatal jaundice. ★
- SN1Classify the tumour markers with their clinical applications and limitations. ★
- SN2Describe the normal composition of cerebrospinal fluid and the changes in meningitis. ★
- SN3Describe the thyroid function tests and their interpretation. ★
- SN4Describe quality control in the clinical biochemistry laboratory. ★
- SN5Describe automation in the clinical biochemistry laboratory with its advantages and limitations.
- SN6Describe the principles and applications of therapeutic drug monitoring.
- SN7Describe the principles of biochemical screening with examples in the newborn and in pregnancy. ★